Switch to:

Beam Therapeutics EV-to-EBITDA

: -14.24 (As of Today)
View and export this data going back to 2020. Start your Free Trial

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Beam Therapeutics's enterprise value is $1,274.36 Mil. Beam Therapeutics's EBITDA for the trailing twelve months (TTM) ended in Mar. 2020 was $-89.52 Mil. Therefore, Beam Therapeutics's EV-to-EBITDA for today is -14.24.

NAS:BEAM' s EV-to-EBITDA Range Over the Past 10 Years
Min: -19.58   Med: 0   Max: 0
Current: -14.24

-19.58
0
NAS:BEAM's EV-to-EBITDA is ranked lower than
99.99% of the 271 Companies
in the Biotechnology industry.

( Industry Median: 30.40 vs. NAS:BEAM: -14.24 )

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2020-07-02), Beam Therapeutics's stock price is $28.61. Beam Therapeutics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2020 was $-2.89. Therefore, Beam Therapeutics's PE Ratio for today is .

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Beam Therapeutics EV-to-EBITDA Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Beam Therapeutics Annual Data
Dec17 Dec18 Dec19
EV-to-EBITDA 0.00 0.00 0.00

Beam Therapeutics Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20
EV-to-EBITDA Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -3.75

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Beam Therapeutics EV-to-EBITDA Distribution

* The bar in red indicates where Beam Therapeutics's EV-to-EBITDA falls into.



Beam Therapeutics EV-to-EBITDA Calculation

Beam Therapeutics's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=1274.359/-89.518
=-14.24

Beam Therapeutics's current Enterprise Value is $1,274.36 Mil.
Beam Therapeutics's EBITDA for the trailing twelve months (TTM) ended in Mar. 2020 was -16.793 (Jun. 2019 ) + -18.741 (Sep. 2019 ) + -26.729 (Dec. 2019 ) + -27.255 (Mar. 2020 ) = $-89.52 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Beam Therapeutics  (NAS:BEAM) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Beam Therapeutics's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=28.61/-2.889827
=

Beam Therapeutics's share price for today is $28.61.
Beam Therapeutics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2020 was -0.600127 (Jun. 2019 ) + -0.364738 (Sep. 2019 ) + -0.894962 (Dec. 2019 ) + -1.03 (Mar. 2020 ) = $-2.89.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Beam Therapeutics EV-to-EBITDA Related Terms


Beam Therapeutics EV-to-EBITDA Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)